Table 2.
Expression of metabolism-related proteins according to breast cancer subtype
| Parameter | Total (n =721) (%) | Luminal A (n =303) (%) | Luminal B (n =169) (%) | HER-2 (n =71) (%) | TNBC (n =178) (%) | P -value |
|---|---|---|---|---|---|---|
| GNMT |
|
|
|
|
|
0.005 |
| Negative |
664 (92.1) |
273 (90.1) |
153 (90.5) |
63 (88.7) |
175 (98.3) |
|
| Positive |
57 (7.9) |
30 (9.9) |
16 (9.5) |
8 (11.3) |
3 (1.7) |
|
| SARDH |
|
|
|
|
|
0.012 |
| Negative |
597 (82.8) |
261 (86.1) |
130 (76.9) |
53 (74.6) |
153 (86.0) |
|
| Positive |
124 (17.2) |
42 (13.9) |
39 (23.1) |
18 (25.4) |
25 (14.0) |
|
| PIPOX (T) |
|
|
|
|
|
0.008 |
| Negative |
570 (79.1) |
225 (74.3) |
143 (84.6) |
52 (73.2) |
150 (84.3) |
|
| Positive |
151 (20.9) |
78 (25.7) |
26 (15.4) |
19 (26.8) |
28 (15.7) |
|
| PIPOX (S) |
|
|
|
|
|
<0.001 |
| Negative |
671 (93.1) |
287 (94.7) |
154 (91.1) |
58 (81.7) |
172 (96.6) |
|
| Positive | 50 (6.9) | 16 (5.3) | 15 (8.9) | 13 (18.3) | 6 (3.4) |
Bold number represents p<0.05.
TNBC, triple negative breast cancer.